UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~June~~December 3031, 2011

o	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number: 0-52556

Card Activation Technologies Inc.

(Exact name of registrant as specified in its charter)

Delaware	20-5769015	~~20-5769015~~
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)	~~(I.R.S. Employer Identification No.)~~
1930 Village Center Circle #3-722 Las Vegas, Nevada		89134
1930 Village Center Cirle #3-722
(Address of principal executive offices)		(Zip Code)
Las Vegas, Nevada	60604-3749
(Address of principal executive offices)	(Zip Code)

(312) 972-1662

(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: ~~Yes x No o~~

Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non–accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b–2 of the Exchange Act.

Large accelerated filer o	Accelerated filer o
Non–Accelerated filer (Do not check if a smaller reporting company) o	Smaller reporting company x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b–2 of the Exchange Act). Yes o No x

As of ~~July~~February 1810, 2011, the issuer had ~~178~~180,~~572~~072,719 shares of common stock, $0.0001 par value per share, outstanding.

TABLE OF CONTENTS

PART I - FINANCIAL INFORMATION	1
ITEM. 1. FINANCIAL STATEMENTS	1
CARD ACTIVATION TECHNOLOGIES INC.
UNAUDITED CONDENSED BALANCE SHEETS	1
CARD ACTIVATION TECHNOLOGIES INC.
UNAUDITED CONDENSED STATEMENTS OF OPERATIONS	2
CARD ACTIVATION TECHNOLOGIES INC.
UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS	3
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	76
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	119
ITEM 4. CONTROLS AND PROCEDURES	119
PART II - OTHER INFORMATION	119
ITEM 1. LEGAL PROCEEDINGS	119
ITEM 6. EXHIBITS	1210

Table of Contents

PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

CARD ACTIVATION TECHNOLOGIES, INC.

CARD ACTIVATION TECHNOLOGIES INC.

UNAUDITED CONDENSED BALANCE SHEETS

	June 30,			September 30,
	December 31, 2011			September 30, 2011
	2011			2010
CURRENT ASSETS
Cash	$	7210,~~462~~516		$	-49,750
Advances to affiliate		-			~~695,777~~-
Other		-			-
Total current assets		10,516			49,750
Total current assets		72,462			695,777
TOTAL ASSETS	$	10,516		$	49,750
TOTAL ASSETS	$	72,462		$	695,777
LIABILITIES AND STOCKHOLDERS' EQUITY:
CURRENT LIABILITIES:
Accounts payable		2,~~083~~232,~~519~~821			~~828~~2,~~808~~204,355
Accrued expenses		13,~~173~~903			1413,~~272~~525
Note payable		15,000			-
Disputed liabilities		20,000			20,000
Total current liabilities		2,~~116~~281,~~692~~724			~~863~~2,~~080~~237,880
TOTAL LIABILITIES		2,~~116~~281,~~692~~724			~~863~~2,~~080~~237,880
STOCKHOLDERS' EQUITY:
Preferred stock, $.001 par value, 1,000,000 shares authorized; none issued and outstanding as of June 30, 2011 and September 30, 2010, respectively		-			-
Preferred stock, $.001 par value, 1,000,000 shares authorized;none issued and outstanding as of December 31, 2011and September 30, 2011, respectively		-			-
Common stock, $.0001 par value, 300,000,000 shares authorized; 178,398,807 and 174,782,045 shares issued and outstanding as of June 30, 2011 and September 30, 2010, respectively		17,840			17,478
Common stock, $.0001 par value, 300,000,000 shares authorized;180,072,719 and 174,782,045 shares issued and outstanding as of December 31, 2011 and September 30, 2011 respectively		18,008			18,008
Additional paid-in capital		1,~~072~~095,~~383~~716			1,~~509~~095,~~953~~716
Common stock, subscribed, 173,912 shares		10,000			35,250
Accumulated deficit		(3,384,932	)		(3,301,854	)
Accumulated deficit		(3,144,453	)		(1,729,984	)
Total stockholders' equity		(2,271,208	)		(2,188,130	)
Total stockholders' equity		(2,044,230	)		(167,303	)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$	10,516		$	49,750
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$	72,462		$	695,777

The accompanying notes are an integral part of these financial statements.

Table of Contents

CARD ACTIVATION TECHNOLOGIES, INC.

UNAUDITED CONDENSED STATEMENTS OF OPERATIONS

	Three Months Ended						Nine Months Ended
	Three Months Ended December 31,
	June 30,						June 30,
	2011			2010
	2011			2010			2011			2010
REVENUE
REVENUE
Litigation revenue	$	-		$	164,000
Litigation revenue	$	-		$	437,500		$	264,000		$	687,500
Total		-			164,000
Total		-			437,500			264,000			687,500
COSTS AND EXPENSES
COSTS AND EXPENSES
Cost of Revenue		-			57,400
Cost of Revenue		-			83,125			92,400			170,625
General and administrative		97,162			424,911
General and administrative		832,313			348,283			1,625,235			670,463
Total operating expenses		97,162			482,311
Sales and marketing expenses		-			-			-			-
OPERATING INCOME (LOSS)		(97,162	)		(318,311	)
Total operating expenses		832,313			431,408			1,717,635			841,088
OTHER (INCOME) AND EXPENSES
OPERATING INCOME (LOSS)		(832,313	)		6,092			(1,453,635	)		(153,588	)
Interest income		(14,461	)		(13,532	)
OTHER (INCOME) AND EXPENSES
Interest expense		377			345
Interest income		(13,298	)		(24,044	)		(40,205	)		(67,162	)
Total other (income) expense		(14,084	)		(13,187	)
Interest expense		349			345			1,039			1,043
INCOME (LOSS) BEFORE INCOME TAXES		(83,078	)		(305,124	)
Total other (income) expense		(12,949	)		(23,699	)		(39,166	)		(66,119	)
INCOME TAX (BENEFIT) PROVISION		-			-
INCOME (LOSS) BEFORE INCOME TAXES		(819,364	)		29,791			(1,414,469	)		(87,469	)
NET INCOME (LOSS)	$	(83,078	)	$	(305,124	)
INCOME TAX (BENEFIT) PROVISION		-			-			-			-
Weighted Average Common Share Outstanding:
NET INCOME (LOSS)	$	(819,364	)	$	29,791		$	(1,414,469	)	$	(87,469	)
Basic and diluted:		180,072,719			176,730,616
Weighted Average Common Share Outstanding:
Net Income (Loss) Per Share
Basic and diluted:	$	~~177,755,897~~(0.00	)	$	~~174,782,045~~(0.00	)		~~176,650,105~~			~~174,782,045~~
Net Income (Loss) Per Share
Basic and diluted:	$	(0.00	)	$	0.00		$	(0.01	)	$	(0.00	)

The accompanying notes are an integral part of these financial statements.

Table of Contents

CARD ACTIVATION TECHNOLOGIES, INC.

UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS

	Nine Months Ended June 30,
	Three Months Ended December 31,
	2011			2010
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$	(183,~~414,469~~078	)	$	(87305,~~469~~124	)
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Discount on common stock issued under subscription agreements		~~82,994~~-			-34,358
Reserve for bad debts		1514,~~168~~461			-13,510
Changes in assets and liabilities:
Other assets		-			~~237~~(6,~~500~~775	)
Accounts payables		128,~~254,711~~466			~~406~~274,~~594~~568
Accrued expenses and disputed liabilities		~~(1,099~~378	)		(~~184~~1,~~232~~794	)
Net cash provided by (used in) operating activities		(6239,~~695~~773	)		~~372~~8,~~393~~743
CASH FLOWS FROM FINANCING ACTIVITIES:
Advances to affiliates		(~~118~~14,~~669~~461	)		(~~382~~15,~~584~~995	)
Proceeds from the sale of common stock, net		141,325			-
Proceeds from note payable		15,000			-
Cash received from subscription of common stock		9,000			-
Proceeds from the sale of common stock, net		-			64,050
Advances from affiliates		103,501			6,708
Net cash provided by (used in) financing activities		539			48,055
Net cash provided by (used in) financing activities		135,157			(375,876	)
INCREASE IN CASH		(39,234	)		56,798
INCREASE IN CASH		72,462			(3,483	)
CASH, BEGINNING OF YEAR		49,750			-
CASH, BEGINNING OF YEAR		-			6,909
CASH, END OF YEAR	$	10,516		$	56,798
CASH, END OF YEAR	$	72,462		$	3,426
Supplemental Cash Flow Information:
Issuance of subscribed stock	$	~~35,250~~-		$	-35,250
Common stock received as loan repayment	$	~~695,777~~-		$	-695,777

The accompanying notes are an integral part of these financial statements

Table of Contents

CARD ACTIVATION TECHNOLOGIES INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)

Note 1. Background

Card Activation Technologies Inc. ("we," "us," "our" or the "Company") was incorporated in the state of Delaware on August 29, 2006. The Company was formed to own and commercially develop our patented point-of-sale technology for the activation and processing of transactions related to debit-styled cards, which include gift cards, phone cards and other stored value cards. ~~Currently,~~The ~~our~~payment ~~business~~technology ~~strategy~~is ~~consists~~covered ~~exclusively~~by ofone ~~attempting~~patent to(U.S. ~~enter~~Patent ~~into~~No. ~~license~~6.032,859, ~~agreements~~entitled ~~with~~‘METHOD ~~third~~FOR ~~parties~~PROCESSING DEBIT PURCHASE TRANSACTIONS USING A COUNTER-TOP TERMINAL SYSTEM’, referred to ~~license~~herein ~~our~~as ~~rights~~the ~~under~~“’859 ~~our~~Patent”). The ~~patent~~‘859 Patent covers the technology and inprocess ~~pursuing~~for ~~patent~~taking ~~litigation~~a incard anwith ~~effort~~a tomagnetic ~~protect~~strip ~~our~~or ~~intellectual~~other ~~property~~data capture mechanism and ~~obtain~~activating ~~recourse~~the ~~against~~card ~~alleged~~by ~~infringement~~down ofloading ~~our~~a ~~patent~~determined monetary value onto the card for use at a later date for different types of transactions.

InCurrently, ~~order to develop~~ our business ~~plan,~~strategy weconsists ~~will~~exclusively ~~require~~of ~~funds~~attempting ~~for~~to ~~working~~enter ~~capital.~~into ~~The~~license ~~Company~~agreements iswith ~~currently~~third ~~being~~parties ~~funded~~to bylicense ~~the~~our ~~sale~~rights ofunder ~~its~~our ~~common~~‘859 ~~stock~~Patent and ~~revenue~~in ~~from~~pursuing patent litigation ~~settlements. The~~in ~~Company~~an ~~anticipates~~effort ~~increasing~~to ~~its~~protect ~~sources~~our intellectual property and obtain recourse against alleged infringement of ~~funds~~our in‘859 ~~the~~Patent. Our ~~future~~ability byto ~~entering~~continue ~~into~~to ~~license~~pursue licensing agreements ~~with~~and ~~third~~patent ~~parties~~litigation to ~~license~~protect our intellectual property is subject to our pending appeals regarding the ~~use~~validity of ~~its~~the ~~patent. However~~'859 Patent, noour ~~such~~principal ~~agreements~~asset, ~~have~~as ~~been~~discussed ~~entered~~below. The ~~into~~‘859 atPatent ~~this~~was ~~time~~transferred to us by MedCom USA, ~~and~~Incorporated ~~the~~(“MedCom’) ~~Company~~upon ~~cannot~~our ~~predict~~formation ~~when,~~in ifexchange ~~ever~~for 146,770,504 itshares ~~will~~of ~~enter~~our ~~into~~common ~~such agreements~~stock.

We were formerly a wholly owned subsidiary of MedCom USA Incorporated ("MedCom"). In connection with our formation, MedCom transferred a patent relating to its card technology business to us in exchange for 146,770,504 shares of our common stock. On October 31, 2006, MedCom's board of directors declared a stock dividend to its shareholders of record at the end of business on December 15, 2006 of one share of our common stock for every one share of common stock of MedCom owned by its shareholders. On March 1, 2007, MedCom distributed 86,770,504 shares of our common stock to its shareholders pursuant to the stock dividend and retained the balance of 60,000,000 shares of our common stock. MedCom remains our largest shareholder.

Note 2. Basis of Presentation

The accompanying condensed financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America ("GAAP") which contemplate continuation of the Company as a going concern. During the three months ended ~~June~~December 3031, 2011, the Company recognized a net loss of $~~819~~83,~~364~~078. The Company has incurred an accumulated net loss from the period August 29, 2006 (inception) through ~~June~~December 3031, 2011 of $3,~~144~~384,~~453~~932. Further, the Company has inadequate working capital to maintain or develop its operations and is dependent upon funds from private investors and the support of certain stockholders.

These factors raise substantial doubt about the ability of the Company to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of these uncertainties. In this regard, our management is proposing to raise any necessary additional funds through a financial institution or through the sale of equity, debt, or a combination of equity and debt, if the Company does not receive additional funding through litigation settlements. There is no assurance that the Company will be successful in raising additional capital.

Table of Contents

The accompanying condensed financial statements included herein have been prepared by us, without audit, in accordance with the accounting policies described in our audited financial statements and notes thereto for the fiscal year ended September 30, ~~2010~~2011, as presented in our annual report on Form 10-K/A, and pursuant to the rules and regulations of the Securities and Exchange Commission, or the SEC. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations, although we believe that the disclosures are adequate to make the information presented not misleading. In the opinion of our management, the accompanying condensed financial statements include all adjustments (consisting only of those of a normal recurring nature), which are necessary for a fair presentation of the results for the interim periods presented. Interim results are not necessarily indicative of results to be expected for any future interim period or for the entire fiscal year.

These condensed financial statements should be read in conjunction with the notes to the audited financial statements presented in our annual report on Form 10-K/A for the year ended September 30, ~~2010~~2011, filed with the SEC. Our reports are available electronically by visiting the SEC website at http://www.sec.gov.

Recent Accounting Guidance

~~On September 30, 2009, the Company adopted updates issued by the Financial Accounting Standards Board ("FASB") to the authoritative hierarchy of GAAP~~ None. These changes establish the FASB Accounting Standards Codification ("ASC") as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in conformity with GAAP. Rules and interpretive releases of the SEC under authority of federal securities laws are also sources of authoritative GAAP for SEC registrants. The FASB will no longer issue new standards in the form of Statements, FASB Staff Positions, or Emerging Issues Task Force Abstracts; instead the FASB will issue Accounting Standards Updates. Accounting Standards Updates will not be authoritative in their own right as they will only serve to update the Codification. These changes and the Codification itself do not change GAAP. Other than the manner in which new accounting guidance is referenced, the adoption of these changes had no impact on the Financial Statements.

In June 2009, the FASB issued guidance now codified as ASC Topic 105, "Generally Accepted Accounting Principles" ("ASC 105"), which establishes the FASB Accounting Standards Codification as the source of GAAP to be applied to nongovernmental agencies. ASC 105 explicitly recognizes rules and interpretive releases of the SEC under authority of federal securities laws as authoritative GAAP for SEC registrants. ASC 105 became effective for interim or annual periods ending after September 15, 2009. ASC 105 does not have a material impact on the Company's financial statements presented hereby.

In May 2009, the FASB issued guidance now codified as ASC Topic 855, "Subsequent Events" ("ASC 855"). The pronouncement modifies the definition of what qualifies as a subsequent event—those events or transactions that occur following the balance sheet date, but before the financial statements are issued, or are available to be issued—and requires a company to disclose the date through which it has evaluated subsequent events and the basis for determining that date. The Company adopted the provisions of ASC 855 on September 30, 2009, in accordance with the effective date.

Table of Contents

On June 30, 2009, the Company adopted updates issued by the FASB to fair value disclosures of financial instruments. These changes require a publicly traded company to include disclosures about the fair value of its financial instruments. Such disclosures include the fair value of all financial instruments for which it is practicable to estimate that value, whether recognized or not recognized in the statement of financial position; the related carrying amount of these financial instruments; and the method(s) and significant assumptions used to estimate the fair value. Other than the required disclosures, the adoption of these changes had no impact on the Financial Statements.

Note 3. Related Party Transactions

As of ~~June~~December 3031, 2011, the Company was managed by its sole officer and director, Robert Kite. Mr. Kite serves as sole director and Chairman of the Company's Board of Directors and acts as the Company's principal executive and principal financial officer. Mr. Kite also serves as chairman of the board of directors, president and chief executive officer of MedCom, a related party, and owns shares of common stock of both MedCom and the Company. MedCom is also a significant shareholder of the Company.

On September 30, 2010, the Company entered into an agreement with MedCom to repay the amount due from advances made in the amount of $1,478,526. The Company agreed to accept shares of its common stock valued at the closing price on the date received. On October 1, 2010, the Company received 8,697,210 shares of its common stock valued at $0.08 per share or $695,777. The Company recorded a reserve for bad debt on the remaining balance of $782,749 for the year ended September 30, 2010.

The Company advances funds to MedCom at a 7% interest rate per annum. As of ~~June~~December 3031, 2011 and September 30, ~~2010~~2011 the Company had receivables from affiliate advances of zero ~~and $695,777, respectively~~.

Note 4. Disputed Liabilities

The Company allegedly is party to a note payable with a principle amount of $20,000 at a 7% interest rate with no due date. The Company is disputing this obligation as management believes that the party entering into the note on behalf of the Company did not have the authority to do so.

~~Note~~ 5~~. Equity~~

The Company periodically issues shares of its common stock to investors in connection with private placement transactions. Absent an arm’s length transaction with an independent third-party, the value of any such issued shares is based on the trading value of the stock at the date of issuance. The Company expenses the difference between the sales price and the fair value of all such issuances in the period incurred. During the three and nine months ended June 30, 2011, the Company issued 1,668,191 and 2,888,191 common shares for cash values of $94,500 and $158,550, respectively. During the three and nine months ended June 30, 2011, the Company recognized an expense related to the trading value of the stock issued in excess of amounts received in the amount of $48,637 and $82,994.

Table of Contents

~~During~~Note ~~the three months ended June 30, 2011 the Company entered into subscription agreements whereby it sold 173,912 shares of common stock to third parties for a value of $10,000~~5. Note Payable

On December 27, 2011, the Company entered into a note payable in the amount of $15,000 due December 26, 2012, bearing interest at 20%. The holder has an option to convert the note to common stock at $0.005 per share during the term of the note. The Company has the right to purchase the note, including interest and conversion rights for $37,500 during the term of the note.

Note 6. Commitments and Contingencies

The Company enters into contingency agreements with law firms that represent the Company in certain of its patent litigations. Under these agreements, the Company typically pays a law firm 35% of the settlement amounts received by the Company and amounts based on future patent litigation successes. Other cases are handled on an hourly fee basis.

Note 7. Litigation

In an action pending in the United States District Court for the District of Delaware, the Court recently ruled that the '‘859 Patent owned by ~~Card~~the ~~Activation~~Company ~~Technologies (“Card”)~~ is invalid. ~~Card~~ The Company’s' only significant asset is the '‘859 Patent. Management disagrees with the Court'’s findings and continues ~~the~~to ~~process~~prosecute an appeal of ~~determining~~this decision before the ~~issues~~United States Court of Appeals for ~~appeal~~the Federal Circuit. Pursuant to a reexamination proceeding, the ~~likely~~United ~~effects~~States ofPatent ~~the~~and ~~Court's~~Trademark ~~ruling~~Office onhas ~~the~~issued ~~pending~~an ~~reexamination~~Final Office Action ruling that all claims of the '859 Patent ~~being~~are ~~conducted~~invalid. Management also disagrees with the findings and determination made by the ~~U.S.~~United States Patent and Trademark Office ~~("PTO"),~~ and ~~the~~continues ~~likelihood~~to ofprosecute ~~success~~an inappeal ~~prevailing~~of ~~against~~the ~~adverse~~determination ~~rulings~~to ~~issued by~~ the ~~Federal~~Board ~~District~~of ~~Court~~Patent Appeals and ~~PTO~~Interferences.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

With the exception of historical facts, the matters discussed in this quarterly report on Form 10-Q are forward-looking statements. Forward-looking statements may relate to, among other things, future actions, future performance generally, business development activities, future capital expenditures, strategies, the outcome of contingencies such as legal proceedings, future financial results, financing sources and availability and the effects of regulation and competition. When we use the words "believe," "intend," "expect," "may," "will," "should," "anticipate," "could," "estimate," "plan," "predict," "project," or their negatives, or other similar expressions, the statements which include those words are usually forward-looking statements. When we describe strategy that involves risks or uncertainties, we are making forward-looking statements.

These forward-looking statements are based on the current plans and expectations of our management and are subject to certain risks and uncertainties that could cause actual results to differ materially from historical results or those anticipated. These factors include, but are not limited to, our ability to protect our patented technology, our failure to satisfy our working capital needs from operations and the availability of and costs associated with potential sources of financing.

We warn you that forward-looking statements are only predictions. Actual events or results may differ as a result of risks that we face. Forward-looking statements speak only as of the date they were made, and we undertake no obligation to update them.

The following discussion contains management's discussion and analysis of financial condition and results of operations. Management's discussion and analysis should be read in conjunction with "Item 1. Financial Statements" of this quarterly report on Form 10-Q and Management's Discussion and Analysis of Financial Condition and Results of Operations presented in our annual report on Form 10-K/A for the fiscal year ended September 30, 2010.6

Table of Contents

Overview

We own and commercially develop our patented method of processing debit purchase transactions, which include gift cards, phone cards and other stored value cards. Currently, our business strategy consists exclusively of attempting to enter into license agreements with third parties to license our rights under our ~~patent~~‘859 Patent and in pursuing patent litigation in an effort to protect our intellectual property and obtain recourse against alleged infringement of our ‘859 Patent. Our ability to continue to pursue licensing agreements and patent litigation to protect our intellectual property is subject to our pending appeals regarding the validity of the ‘859 Patent. If the pending appeals concerning the ‘859 Patent result in a favorable determination of validity, we intend to aggressively enforce our rights during the remaining life of the ‘859 patent, and to seek royalty payments from all infringing parties until the ‘859 Patent expires in 2017.

Results of Operations

Three Months Ended ~~June~~December 3031, 2011, Compared to Three Months Ended ~~June~~December 3031, 2010

Revenues decreased to zero for the three months ended ~~June~~December 3031, 2011, compared to $~~437~~164,~~500~~000 for the three months ended ~~June~~December 3031, 2010. The decrease in revenues was due to no settlements for the three months ended ~~June~~December 3031, 2011 compared to ~~two~~three for the three months ended ~~June~~December 3031, 2010.

Operating expenses consist of cost of revenue, general and administrative expenses and sales and marketing costs.

Cost of revenue consists of contingency fees paid to legal counsel equal to 35% of settlement revenue. Certain of our settlements are not subject to contingency fees. Cost of revenue decreased to zero for the three months ended ~~June~~December 3031, 2011 from $8357,~~125~~400 for the three months ended ~~June~~December 3031, 2010 as a result of no settlements for the three months ended ~~June~~December 3031, 2011 compared to ~~two~~three for the comparable period in 2010.

General and administrative expenses consist of salaries and benefits, legal, professional and consulting fees, corporate costs, facilities costs, insurance, travel and entertainment. General and administrative costs ~~increased~~decreased ~~139~~77.01% to $~~832~~97,~~213~~162 for the three months ended ~~June~~December 3031, 2011 from $~~348~~424,~~283~~911 for the three months ended ~~June~~December 3031, 2010. This increase was primarily due to ~~additional~~decreased legal fees.

~~Nine Months Ended June 30, 2011, Compared to Nine Months Ended June 30, 2010~~7

Revenues decreased to $264,000 for the nine months ended June 30, 2011, compared to $687,500 for the nine months ended June 30, 2010. The decrease in revenues was due to four smaller settlement amounts during the nine months ended June 30, 2011 compared to four during the nine months ended June 30, 2010, primarily due to settling with retailers which have less volume utilizing our patent.

Operating expenses consist of cost of revenue, general and administrative expenses and sales and marketing costs.

Cost of revenue consists of contingency fees paid to legal counsel equal to 35% of settlement revenue. Certain of our settlements are not subject to contingency fees. Cost of revenue decreased $78,225 to $92,400 for the nine months ended June 30, 2011 from $170,625 for the nine months ended June 30, 2011 as a result of four lower settlement amounts during the nine months ended June 30, 2011 compared to four higher settlement amounts in 2010.

Table of Contents

General and administrative expenses consist of salaries and benefits, legal, professional and consulting fees, corporate costs, facilities costs, insurance, travel and entertainment. General and administrative costs increased 142.4% to $1,625,235 for the nine months ended June 30, 2011 from $670,463 for the nine months ended June 30, 2010. This increase was primarily due to additional legal fees.

Liquidity and Capital Resources

Our primary sources of liquidity are the sale of our common stock, cash borrowings and cash generated from operations. We ~~sold~~borrowed 2$15,~~888,191~~000 ~~shares~~with ofa ~~common~~12 ~~stock,~~month ~~issued~~term ~~728,571 shares of common stock for previous subscription agreements~~ and ~~entered~~interest ~~into~~rate ~~subscription agreements to sell 173,912 shares~~ of ~~our~~20% ~~common stock and received four settlements~~ during the ~~nine~~three months ended ~~June~~December 3031, 2011.

The Company’s ~~anticipates~~operating ~~increasing~~requirements ~~its~~have ~~sources~~historically ofbeen ~~funds~~funded infrom the ~~future~~sale ~~by entering into license agreements with third parties to license the use~~ of ~~its~~our ~~patent. However,~~common nostock ~~such agreements have been entered into at this time,~~ and ~~the~~litigation ~~Company~~settlement ~~cannot predict when, if ever, it will enter into such agreements~~revenue. ~~Management~~Subject ~~anticipates~~to ~~that~~ the ~~Company's~~pending ~~current~~appeals ~~funds~~regarding ~~will be able to sustain~~ the ~~Company~~‘859 ~~through~~Patent ~~the~~discussed ~~end of the fiscal year~~above, atwe ~~which~~expect ~~point~~our ~~the~~future ~~Company~~operations ~~may~~will be ~~required~~funded tofrom ~~seek additional financing through a financial institution or through~~ the ~~sale~~litigation ofrevenue ~~equity,~~settlements ~~debt,~~as orwell aas ~~combination~~revenues offrom ~~equity~~licensing orour ~~debt,~~technology. In ifaddition the Company ~~has~~is ~~not~~researching ~~received~~potential ~~additional~~business ~~funding~~combinations ~~through litigation settlements at~~ that ~~time. The~~would ~~Company~~utilize ~~does~~our ~~not~~technology ~~have~~or ~~any~~enhance ~~contractual~~our ~~commitments~~strategy, ~~that~~although ~~would~~no besuch ~~impacted~~target byacquisition ahas ~~loss~~been ~~of funding at this time~~identified.

~~From~~In ~~time~~order to ~~time~~develop ~~the~~our ~~Company~~business ~~advances~~plan, we will require funds tofor ~~MedCom~~working capital. AsWe ofare ~~June~~attempting 30to raise additional working capital through the sale of equity, ~~2011~~debt or a combination of equity and debt. We do not presently have any firm commitments for additional working capital and there ~~were~~are no ~~outstanding~~assurances ~~amounts~~that such capital will be available to us when needed or upon terms and conditions which are acceptable to us. If we are able to secure additional working capital through the sale of equity securities, the ownership interests of our current stockholders will be diluted. If we raise additional working capital through the issuance of debt or additional dividend paying securities our future interest and dividend expenses will increase. If we are unable to secure additional working capital as needed, our ability to grow our sales, meet our operating and financing obligations as they become due ~~from~~and ~~related~~continue ~~parties~~our business and operations could be in jeopardy.

AtThe ~~June~~Company ~~30,~~is ~~2011,~~currently webeing ~~had~~funded ~~cash~~by the sale of ~~$72~~its common stock and revenue from litigation settlements. Subject to the pending appeals regarding the ‘859 Patent discussed above,~~462~~ ~~compared~~the Company anticipates increasing its sources of funds in the future by entering into license agreements with third parties to $0license the use of its ‘859 patent. However, no such agreements have been entered into at ~~September~~this 30time, ~~2010~~and the Company cannot predict when, if ever, it will enter into such agreements. ~~The~~Management ~~net~~anticipates ~~change~~that inthe ~~cash~~Company’s ~~for~~current funds will be able to sustain the ~~periods~~Company ~~presented~~through ~~was~~the ~~comprised~~next three to six months, at which point the Company may be required to seek additional financing through a financial institution or through the sale of equity, debt, or a combination of equity and debt, if the ~~following:~~Company has not received additional funding through litigation settlements at that time. The Company does not have any contractual commitments that would be impacted by a loss of funding at this time.

	June 30, 2011			June 30, 2010
Cash flow provided by (used in) operating activities	$	(62,695	)	$	372,393
Cash flow provided by (used in) financing activities		135,157			(375,876	)

From time to time the Company advances funds to MedCom. As of December 31, 2011 there were no outstanding amounts due from related parties.

Cash flow from operating activities was primarily due to net loss of $1,414,469 offset by an increase in accounts payable of approximately $1,255,000 for the nine months ended June 30, 2011. For the nine months ended June 30, 2010, cash flow from operating activities was primarily due to net loss of $87,469, an increase in other assets and accounts payable offset by a decrease in accrued expenses.

Cash flow from financing activities was due to sale of stock and stock subscriptions of $150,000 offset by a net advance to affiliate of $15,000 for the nine months ended June 30, 2011 compared to net advances to affiliates of approximately $376,000 for the nine months ended June 30, 2010.

Table of Contents

Recently Issued Accounting Guidance

~~On September 30, 2009, the Company adopted updates issued by the Financial Accounting Standards Board ("FASB") to the authoritative hierarchy of GAAP~~None. These changes establish the FASB Accounting Standards Codification ("ASC") as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in conformity with GAAP. Rules and interpretive releases of the Securities and Exchange Commission ("SEC") under authority of federal securities laws are also sources of authoritative GAAP for SEC registrants. The FASB will no longer issue new standards in the form of Statements, FASB Staff Positions, or Emerging Issues Task Force Abstracts; instead the FASB will issue Accounting Standards Updates. Accounting Standards Updates will not be authoritative in their own right as they will only serve to update the Codification. These changes and the Codification itself do not change GAAP. Other than the manner in which new accounting guidance is referenced, the adoption of these changes had no impact on the Financial Statements.

InTable ~~May 2009, the FASB issued guidance now codified as ASC Topic 855, "Subsequent Events" ("ASC 855"). The pronouncement modifies the definition~~ of what qualifies as a subsequent event—those events or transactions that occur following the balance sheet date, but before the financial statements are issued, or are available to be issued—and requires companies to disclose the date through which the company has evaluated subsequent events and the basis for determining that date. The Company adopted the provisions of ASC 855 on September 30, 2009, in accordance with the effective date.Contents

On June 30, 2009, the Company adopted updates issued by the FASB to fair value disclosures of financial instruments. These changes require a publicly traded company to include disclosures about the fair value of its financial instruments. Such disclosures include the fair value of all financial instruments, for which it is practicable to estimate that value, whether recognized or not recognized in the statement of financial position; the related carrying amount of these financial instruments; and the method(s) and significant assumptions used to estimate the fair value. Other than the required disclosures, the adoption of these changes had no impact on the Financial Statements.

Other Considerations

There are numerous factors that affect the business and the results of our operations. Sources of these factors include general economic and business conditions, federal and state regulation of business activities, the level of demand for our product, and the ability to develop new products based on new or evolving technology and the market's acceptance of those products.

Table of Contents

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our principal executive officer, who also serves as our principal financial officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as such term is defined under Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), as of the end of the period covered by this report. Based on that evaluation, our principal executive officer has concluded that our disclosure controls and procedures are not effective for ensuring that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms. We are in the process of evaluating our disclosure controls and procedures in an effort to develop remedial measures to correct the deficiencies.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during our last fiscal quarter (the quarter ended ~~June~~December 3031, 2011) that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

Table of Contents

In the ordinary course of business, we are the subject of, or party to, various pending or threatened legal actions, including various counterclaims in connection with our intellectual property enforcement activities. The Company, through its attorneys, has sent letters to over 600 potential infringers of the patent, placing the infringers on notice of the patent and seeking a license agreement under the patent. While we believe that any liability arising from these actions will not have a material adverse effect on our financial position, results of operations or cash flows, we can make no assurances that we will not lose all or some of the claims covered by our patent as the result of such actions.

Information regarding the Company's legal proceedings outside the ordinary course of business is disclosed under Notes 3 and 4 to the Company's Condensed Financial Statements (unaudited) of Part I of this Quarterly Report on Form 10-Q, which is incorporated herein by reference.

Table of Contents

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

During the three months ended June 30, 2011, the Company continued its private offering (the "Private Offering") of shares of common stock (the "Common Stock") of the Company. To date, the Company has sold a total of 3,790,674 shares of Common Stock through the Private Offering for an aggregate price of $203,800. Total commissions paid to date with respect to the sale of the Common Stock are $18,225. The Private Offering is being conducted pursuant to an exemption from registration under Regulation D of the Securities Act of 1933, as amended. The Company believes it falls within this exemption because (i) it has not sold and does not intend to sell Common Stock in the Private Offering to more than 35 purchasers (calculated pursuant to Rule 501(e)); and (ii) each purchaser of the Common Stock pursuant to the Private Offering is either an accredited investor or, if not an accredited investor, the Company reasonably believes that the purchaser, either alone or with his purchaser representative(s), has such knowledge and experience in financial and business matters that the purchaser is capable of evaluating the merits and risks of the prospective investment.

ITEM 6. EXHIBITS

31.1	Certification of Principal Executive and Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act

32.1	Certification of Principal Executive and Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act

101.INS

XBRL Instance Document

101.SCH

XBRL Taxonomy Extension Schema Document

101.CAL

XBRL Taxonomy Extension Calculation Linkbase Document

101.LAB

XBRL Taxonomy Extension Label Linkbase Document

101.PRE

XBRL Taxonomy Extension Presentation Linkbase Document

1210

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		Card Activation Technologies Inc.
Dated: August 1, 2011	By:	/s/ Robert Kite
Dated: February 10, 2011	By:	/s/ Robert Kite
		Robert Kite
		Chairman, President and Chief Executive Officer
		(Principal Executive Officer and Principal Financial Officer)

13 11

Filing Compare · Card Activation Technologies Inc